Skip to main content
Quest Diagnostics Home

Assessing Alzheimer's Disease Risk in Primary Care Settings

Assessing Alzheimer's Disease Risk in Primary Care Settings Through Blood-based Biomarkers

On-Demand:

The objectives of this webinar include:

 

•  Discuss the rising prevalence of Alzheimer’s disease

 

•  Outline current challenges in assessing and monitoring Alzheimer’s disease

 

•  Illustrate the role of blood-based biomarkers in primary care settings

 

•  Explore emerging treatments and new diagnostic pathways

 

P.A.C.E credits, click here, will be available to participating laboratory professionals who attend the webinar and complete the post evaluation. P.A.C.E credit expires on 12/8/2022.

 

 

Date:
Jun 08, 2022
Location:
Virtual - LIVE Webinar
:
Dr Michael K. Racke & Dr Roberto Fernandez-Romero & moderated by Gabriele Olla

Michael K. Racke, MD

Roberto Fernandez-Romero, MD, MPH, PhD

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2023 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.